BMND08
- Generic Name
- BMND08
Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Procedure: Brain electrical activity monitorDiagnostic Test: Biochemical determinationsDiagnostic Test: Pharmacokinetic Study of Sublingually Administered Psychoactive SubstanceDiagnostic Test: Acute Subjective Ratings of Psychedelic EffectsDiagnostic Test: vital signsDiagnostic Test: Cognitive AssessmentsDiagnostic Test: Psychiatric Assessments
- First Posted Date
- 2025-02-10
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Biomind Labs Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06816667
- Locations
- 🇦🇷
Hospital Descentralizado Dr. Marcial V. Quiroga., San Juan, Rivadavia, Argentina
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath